Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Human hair loss may have evolved to help increase brain size.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

Exosomal miRNAs from stem cells can help improve skin health and delay aging.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Transplantation is effective for stable leucoderma but not for progressive, widespread vitiligo vulgaris.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Targeting ornithine decarboxylase can help prevent skin cancer.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Activating Notch signaling can kill basal cell carcinoma cells.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.